0 CHECKOUT

PRODUCT FILTERS

REGION

15
2
1
1
1

COUNTRY

1
1
1

CATEGORIES

  • 68
  • 16
  • 11
  • 7
  • 7
  • 6
  • 5
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

9
10
89
136

PUBLISHED

0
20
67
136

PRODUCT TYPE

126
6
4

Search for: "Merck KGaA-Therapeutic Competitors Report"

136 Products

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 Kalorama Information's Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 takes a considered...

Published:  April 2014
Price:  From

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies

The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies...

Published:  March 2014
Price:  From
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies - Product Thumbnail Image

IMS Company Profiles:Merck KGaA

IMS Company Profiles gives a clear picture of the companies' strengths in terms of therapy areas and relevant marketed products as well as the future strategic direction of companies including R&D pipelines,...

Published:  October 2013
Price: 

Lung Cancer Clinical Trial Overview

This report provides insight into the current clinical trial activity surrounding lung cancer by examining industry-sponsored activities and quantifying important development milestones and trial metrics: -...

Published:  March 2014
Price:  From

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015 Summary This, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015’, provides an overview of the...

Published:  February 2015
Price:  From

Women Infertility - Pipeline Review, H1 2014

Women Infertility - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Women Infertility - Pipeline Review, H1 2014’, provides an overview of the Women Infertility’s therapeutic pipeline. This...

Published:  February 2014
Price:  From

Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016

What Will the Pharma Industry Look Like in 5 Years? There are an estimated 724 projects in development from the top 50 pharmaceutical companies.  Together, they have the potential to add billions...

Published:  August 2012
Price:  From

Endometrial Cancer - Pipeline Review, H1 2015

Endometrial Cancer - Pipeline Review, H1 2015 Summary This, ‘Endometrial Cancer - Pipeline Review, H1 2015’, provides an overview of the Endometrial Cancer’s therapeutic pipeline. This report provides...

Published:  May 2015
Price:  From

Rectal Cancer - Pipeline Review, H1 2014

Rectal Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Rectal Cancer - Pipeline Review, H1 2014’, provides an overview of the Rectal Cancer’s therapeutic pipeline. This report...

Published:  February 2014
Price:  From

Polycystic Ovarian Syndrome - Pipeline Review, H1 2015

Polycystic Ovarian Syndrome - Pipeline Review, H1 2015 Summary This, ‘Polycystic Ovarian Syndrome - Pipeline Review, H1 2015’, provides an overview of the Polycystic Ovarian Syndrome’s therapeutic...

Published:  January 2015
Price:  From

Polycystic Ovarian Syndrome - Pipeline Review, H2 2014

Polycystic Ovarian Syndrome - Pipeline Review, H2 2014 Summary This, ‘Polycystic Ovarian Syndrome - Pipeline Review, H2 2014’, provides an overview of the Polycystic Ovarian Syndrome’s therapeutic...

Published:  September 2014
Price:  From

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2014

Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2014 Summary This, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2014’, provides an overview of the...

Published:  December 2014
Price:  From

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2015

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2015 Summary This, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2015’, provides an overview of the...

Published:  April 2015
Price:  From

Cartilage Degeneration - Pipeline Review, H1 2014

Cartilage Degeneration - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cartilage Degeneration - Pipeline Review, H1 2014’, provides an overview of the Cartilage Degeneration’s therapeutic...

Published:  May 2014
Price:  From

Indolent Lymphoma - Pipeline Review, H1 2014

Indolent Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline. This...

Published:  April 2014
Price:  From

Indolent Lymphoma - Pipeline Review, H1 2015

Indolent Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Indolent Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline. This report provides...

Published:  January 2015
Price:  From

Gastric Cancer - Pipeline Review, H1 2015

Gastric Cancer - Pipeline Review, H1 2015 Summary: This, ‘Gastric Cancer - Pipeline Review, H1 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline. This report provides...

Published:  March 2015
Price:  From

Type 2 Diabetes - Pipeline Review, H2 2014

Type 2 Diabetes - Pipeline Review, H2 2014 Summary This, ‘Type 2 Diabetes - Pipeline Review, H2 2014’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides comprehensive...

Published:  October 2014
Price:  From

Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2014

Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2014’, provides an overview of the Leishmaniasis (Kala-Azar)’s...

Published:  March 2014
Price:  From

Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2014

Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2014 Summary This, ‘Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2014’, provides an overview of the Leishmaniasis (Kala-Azar)’s therapeutic pipeline. This...

Published:  September 2014
Price:  From
Loading Indicator

Our Clients

  • Carrefour S.A.
  • Dow Chemical Co Ltd.
  • Motorola Solutions, Inc.
  • Pfizer, Inc.
  • Activision Publishing, Inc.
  • 3M Company
  • Estée Lauder Companies Inc.